Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- Countryside Properties Sees Broadly Flat Performance In Third Quarter
25 Jul 2019 - UK Earnings, Trading Statements Calendar - Next 7 Days
18 Jul 2019 - Friday broker round-up
28 Jun 2019 - Thursday broker round-up
27 Jun 2019 - Woodford Raises Further GBP84 Million From London Stake Sales (ALLISS)
18 Jun 2019 - Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)
10 Jun 2019 - DIRECTOR DEALINGS: Countryside Non-Executive's Associate Buys Shares
7 Jun 2019 - Thursday broker round-up
16 May 2019
Related News
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
CSP.L News
Countryside Properties Sees Broadly Flat Performance In Third Quarter
(Alliance News) - Countryside Properties PLC on Thursday said it expects to deliver growth in its current financial year as it saw an increased demand...
UK Earnings, Trading Statements Calendar - Next 7 Days
Friday 19 July Close BrothersTrading StatementRecordQ1 StatementSSP 22
Friday broker round-up
(Sharecast News) - QinetiQ: Credit Suisse downgrades to neutral with a target price of 325p.
Thursday broker round-up
(Sharecast News) - Rightmove: UBS downgrades to sell with a target price of 505p.
Woodford Raises Further GBP84 Million From London Stake Sales (ALLISS)
(Alliance News) - After a raft of London share sales in early June, Neil Woodford's Woodford Investment Management slowed its rate of listed-company d...
Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)
LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20...
DIRECTOR DEALINGS: Countryside Non-Executive's Associate Buys Shares
LONDON (Alliance News) - Countryside Properties PLC said that Sally Louise Townsend, an associate of Non-Executive Director Simon Townsend, purchased ...
Thursday broker round-up
(Sharecast News) - Grainger: Numis downgrades to add with a target price of 295p.
Follow the stocks
